Exchange: NASDAQ·Updated 07:30 PM EST
FEMY logo

FEMY Femasys Inc

$1.24
$0.02
(1.59%)
Today
Closed $1.24
$0.00
(0.00%)
After Hours
Mkt Cap$10.73M
Vol95,628.00

About FEMY

Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.
56

Bullish Sentiment

How do you feel about FEMY?

MrMcFlurry
$FEMY people may not realize how much time it takes to get the word out on new medical procedures and how long it takes for prospective customers to become aware of it, but as it rolls out to more distributors and they roll it out to more offices and flyers are put in the rooms the more people will begin to try it out. And if it is actually effective, the confidence will build. The procedures are just beginning to roll out to offices across the US and adoption rates will vary. But there are 15,000+ offices in the US. They are just beginning to establish a footprint.
7
Zaksab
$FEMY I stagger to think any serious investors paid 3.20 for 30m of this lifestyle money pit
1
2
MrMcFlurry
$FEMY what I like is that revenue increased even before they had funds to build out their distribution network more. The next two quarters will be telling about how much runway they have and how much their focus on getting established participation will matter to the ramp. Medical stuff takes a good bit of time but once it’s established, it’s durable.
4
beaches911
$FEMY just amazes me how the board can leave such an inept ceo continue, this company will just continue to decline due to gross stupidity of the woman
4
beaches911
$FEMY femaseed has been approved now for years they cannot sell it, they cannot sell fembloc in Europe, a company incapable off marketing their own products and an incompetent ceo, if it was a man they would have been fired years ago
4
TripTrap
$FEMY Unusual close today for FEMY… Whenever we have a rare up day, traders usually sell into the close… This was an up day and traders actually bought into the close… Maybe news comes out tomorrow...who knows… 
3
MrMcFlurry
$FEMY currently market cap is $12MM with future warrants under water. We’d have to reach $3 to make sense of any warrants being exercised. But I want to see revenue growth in areas where they have worked with providers to get the product in offices. Any data at this point would be useful. Would love to see the transcript for future earnings calls. Would love to know when they plan to hit $5MM per quarter revenue. I don’t believe it will be this year.
3
Severian1
$FEMY even if revenue is a beat. i dont see significant price change until FDA approval for Fembloc. I could be wrong i dont think i am. 2-3 years away still in my opinion from not being a sub $4 stock
3
dongknotts
$FEMY Drop a big European sales contract already! Prove that the executives are not overpaid grifters!!! We might see a price jump when the FINALE trial is fully enrolled but for now the only thing I see to make this go is a significant order to Europe for Fembloc, FemSeed is much less important, any increase in revenue would be good but the market for non-surgical permanent birth control is much bigger.
3
dongknotts
$FEMY The recent warrant structure is actually pretty good. Only some are immediately exercisable at 2.95, others are tied to revenue and share price increase. I don't view 2.95 as the ceiling, closer to $4.00 because half of the warrants are milestone warrants only excercisable ones the price is over $3.85 for a period of time and they need to have a quarter with $1.5 million in revenue or better. If the plan comes together, the stock price needs to be over $4.00. They have lots of cash despite too much executive compensation however, this may be a good entry point. I was waiting for $1.35 but i took a position at $1.49 today. Only the August 2026 warrants are relevant, prior warrants when adjusted for the RS are $15-20.
3
Rayvio_News_Filter
$FEMY 💰 Femasys Inc. completed a $30 million private placement with potential total proceeds of up to $85 million to support commercial team build-out and drive U.S. sales growth. Timely market event
2
Airdvl
$FEMY i am guessing anything earned.This year will be for equipment and training , with twenty twenty seven being the year that the c p t codes for insurance payment goes into effect. Please correct me if i'm wrong
2
dongknotts
$FEMY this is starting to look cheap, can double your money before reaching the warrant overhang but if there is no meaningful growth in sales, probably the products just will never take off. A meaningful European Fembloc order would be enough for this to get back near $3. If aales are stagnant under Canning, perhaps he should go.
2
Severian1
$FEMY revenue doesnt even matter (maybe itll matter in ten years if the company becomes self-sustaining and profitable), its buyout or bust here for shareholders
1
TripTrap
$FEMY “They did not reorder.”?? Why not read the filing? The distributors are working through existing bulk inventory to run the European post-market studies; reorders come after those wrap. That’s how distributor bulk-ordering works; you don’t reorder until the shelf is empty. You’re reading “we have inventory to use up” as “nobody wants it.” Those aren’t the same thing, and the 10-Q spells out the difference if you’d bothered. Meanwhile US sales, the ones they sell directly, went up. Odd thing for a product “they can’t sell.”
1
Ked1977
$FEMY or the fact they they have continued to allow the exorbitant compensation these worthless executives are getting. They miss either know something we don’t or they are suckers.
1
Zaksab
$FEMY surely they would have if serious (and real…) gotten onto the board sacked most people etc
1
Severian1
$FEMY for all its patheticness it has bounced off of 1.45 a few times in the last month
1

Advertisement|Remove ads.